Brief Summary

The possibility of registering the M-response and the motor evoked potential (MEP) from the muscles of the tongue by using the St. Mark's electrode will be evaluated. The safety of method will be confirmed. Registered parameters will be compared with other known methods and comparative effectiveness of proposed method will be determined. The study will involve healthy volunteers without clinical symptoms of hypoglossal nerve and cortico-lingual pathway lesions and without surgical interventions in the tongue .The volunteers will be examined once for the parameters of the amplitude and latency of the M-response and MEP, as well as the difference between these indicators at different sides of the examination during nerve conduction study (NCS) and transcranial magnetic stimulation (TMS) of the hypoglossal nerve and the cortico-lingual pathway.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable healthy-volunteers

Timeline
Completed

Started Oct 2021

Shorter than P25 for not_applicable healthy-volunteers

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 23, 2021

Completed
8 days until next milestone

Study Start

First participant enrolled

October 1, 2021

Completed
6 days until next milestone

First Posted

Study publicly available on registry

October 7, 2021

Completed
13 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 20, 2021

Completed
21 days until next milestone

Study Completion

Last participant's last visit for all outcomes

November 10, 2021

Completed
Last Updated

November 26, 2021

Status Verified

November 1, 2021

Enrollment Period

19 days

First QC Date

September 23, 2021

Last Update Submit

November 24, 2021

Conditions

Keywords

hypoglossal nerve

Outcome Measures

Primary Outcomes (1)

  • Severe adverse reactions and events rate

    Severe adverse reactions and events will be monitored and registered during procedure of nerve stimulation and on the day of study

    During the intervention and 1 day after the intervention

Secondary Outcomes (2)

  • Rate of M-wave registration during NCS of hypoglossus nerve using the St. Mark's electrode in healthy volunteers.

    During the intervention

  • Rate of MEP registration during TMS of cortical-lingual pathway using the St. Mark's electrode in healthy volunteers.

    During the intervention

Study Arms (1)

Hypoglossal nerve conduction study.

EXPERIMENTAL
Diagnostic Test: Hypoglossal nerve conduction studyDiagnostic Test: Transcranial magnetic stimulation of hypoglossal nerve

Interventions

NCS of nervus hypoglossus (evaluation of M-response parameters) was carried out using a 4-channel electromyographic machine. The stimulation will be carried out from three points: 1. angle of the lower jaw (proximal point), 2. the area of the carotid triangle (distal point), 3. directly from the electrode of St. Mark when it is localized on the muscles of the tongue. The initial stimulation parameters: strength of an electric current 20 mA, stimulus duration 0.2 ms, and frequency 1 Hz. To achieve supramaximal stimulation, the stimulation strength will be increased with a step of 1-2 mA to a maximum of 35 mA, the duration of the stimulus will be increased to 0.3 ms.

Hypoglossal nerve conduction study.

TMS will be carried out using a Magstim 200 magnetic stimulator connected with a BiStim module (Magstim Co. Ltd., Whitland, Wales, UK). The generated magnetic pulses will be delivered by the coil 65 mm in diameter tangentially located relative to the scalp in the F7 projection - T3 and F8-T4 (according to the international scheme "10-20"). The area of cortical stimulation will be localized by supplying single pulses with gradual increase, with a coil displacement with a step of 1 cm, until the contraction of the facial muscles will be obtained, followed by the determination of the MEP threshold value. Analysis of conduction by cortical-lingual pathway will be performed at TMS with magnetic stimulus intensity 20-30% above the MEP threshold.

Hypoglossal nerve conduction study.

Eligibility Criteria

Age18 Years - 30 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Absence of clinical symptoms of impaired hypoglossal nerve and cortico-lingual pathways;
  • Absence of history of surgical interventions in the tongue area;
  • The subject has read the information sheet and signed the informed consent.

You may not qualify if:

  • Clinical symptoms of hypoglossal nerve or cortico-lingual pathway (dysarthria, dysphagia (pseudobulbar palsy) lesions, flaccid paralysis of the tongue muscles, atrophy and fasciculations of the tongue muscles);
  • Tumors, metastatic lesions and cysts in the region of the brain stem, posterior cranial fossa, base of the skull, in the region of the carotid segment, salivary glands;
  • Vascular pathologies in the carotid sinus area: vascular malformations, dissection of the internal carotid artery aneurysm, venous thrombosis;
  • Recent dental procedures with one of the following complications: development of an abscess, direct injury to the nerve by medical equipment, development of hematoma;
  • History of carotid endarterectomy;
  • Motor neuron disease and other neurodegenerative or demyelinating diseases;
  • History of cancer and courses of radiation therapy;
  • The presence of implantable programmable devices.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Pirogov National Medical and Surgical Center

Moscow, 105064, Russia

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 23, 2021

First Posted

October 7, 2021

Study Start

October 1, 2021

Primary Completion

October 20, 2021

Study Completion

November 10, 2021

Last Updated

November 26, 2021

Record last verified: 2021-11

Data Sharing

IPD Sharing
Will share
Shared Documents
CSR
Time Frame
2 months after completion of the study
Access Criteria
upon the request

Locations